Highline Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Sell
932
-22
-2% -$2.58K 0.02% 151
2026
Q1
$115K Buy
954
+186
+24% +$21.5K 0.03% 115
2025
Q4
$80.8K Sell
768
-9,905
-93% -$930K 0.02% 106
2025
Q3
$896K Buy
10,673
+73
+0.7% +$6.01K 0.24% 60
2025
Q2
$839K Buy
10,600
+310
+3% +$24.6K 0.25% 58
2025
Q1
$924K Sell
10,290
-63
-0.6% -$5.88K 0.31% 56
2024
Q4
$1.03M Sell
10,353
-26
-0.3% -$2.68K 0.34% 53
2024
Q3
$1.18M Buy
10,379
+119
+1% +$14.1K 0.39% 51
2024
Q2
$1.27M Buy
10,260
+142
+1% +$18.3K 0.48% 46
2024
Q1
$1.34M Hold
10,118
0.54% 41
2023
Q4
$1.1M Hold
10,118
0.53% 45
2023
Q3
$1.04M Buy
10,118
+24
+0.2% +$2.59K 0.64% 39
2023
Q2
$1.16M Hold
10,094
0.73% 36
2023
Q1
$1.07M Buy
10,094
+7
+0.1% +$756 0.73% 39
2022
Q4
$1.12M Hold
10,087
0.83% 35
2022
Q3
$869K Buy
+10,087
New +$900K 0.71% 37

Other funds holding MRK

Highline Wealth Partners's MRK Position: Q2 2026 in Review

Highline Wealth Partners reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $2.58K and leaving 932 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #151.

Highline Wealth Partners first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.34M in Q1 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Highline Wealth Partners held 932 shares of Merck worth $120K as of Q2 2026.
  • Highline Wealth Partners sold 22 Merck shares in Q2 2026, an estimated $2.58K.
  • Merck made up 0.02% of Highline Wealth Partners's portfolio in Q2 2026, its #151 holding.
  • Highline Wealth Partners first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's Merck position peaked at $1.34M in Q1 2024.
  • 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.